MD Anderson Cancer Center
1515 Holcombe Boulevard
200 articles with MD Anderson Cancer Center
Bayer and MD Anderson Cancer Center Collaborate to Strengthen Oncology Translational Research and Clinical Development
Five-year agreement to accelerate early clinical development of selected Bayer drug candidates
Amgen And MD Anderson Announce Collaboration To Accelerate Early Stage Treatments For Leukemia, Myelodysplastic Syndromes, Multiple Myeloma, Small-Cell Lung And Other Small-Cell Cancers
Amgen and The University of Texas MD Anderson Cancer Center announced two multi-year collaboration agreements aimed at accelerating development of a variety of Amgen's early-stage oncology therapies for patients with leukemia, myelodysplastic syndromes, multiple myeloma, small-cell lung cancer, and other non-lung cancers with small-cell histologies.
New Study from MD Anderson Cancer Center: Intraoperative Specimen Tomosynthesis Improves Margin Assessment in Breast Conservation Surgery
Tomosynthesis is highly accurate for detecting positive margins intra-operatively, compared to traditional 2-D imaging with extensive processing, in breast cancer patients undergoing segmental mastectomy.
MD Anderson and Berkeley Lights Launch Optera Therapeutics to Accelerate Development of Cell Therapies for Cancer
Optera Therapeutics will develop cancer cell therapies discovered at MD Anderson and apply Berkeley Lights' advanced cell therapy manufacturing systems with the goal of making these novel therapies accessible to all.
The University of Texas MD Anderson Cancer Center and RaySearch Laboratories today announced a strategic alliance with the aim of enhancing cancer radiation therapy.
Seres Therapeutics, MD Anderson Cancer Center, and the Parker Institute for Cancer Immunotherapy Announce a Collaboration to Support the Investigation of Microbiome Therapeutics for Immuno-Oncology
The collaborators plan to initiate a randomized, placebo-controlled clinical study at MD Anderson, sponsored by the Parker Institute, in patients with advanced metastatic melanoma.
University of Texas MD Anderson Cancer Center Release: Andrew Sabin Family Fellows To Receive $100,000 In Research Funding
American Dental Association And The University of Texas MD Anderson Cancer Center Announce Collaboration
Jiangsu Hengrui Medicine Co. Ltd. Enters Into Agreement With The University of Texas MD Anderson Cancer Center To Advance Immunotherapy And Precision Medicine For Cancer Treatment
Helsinn Healthcare SA,The University of Texas MD Anderson Cancer Center Enter Strategic Alliance To Improve Life Of Patients Conducting Clinical Studies In Cancer Supportive And Palliative Care
Karus Therapeutics Announces Strategic Collaboration With University of Texas MD Anderson Cancer Center
New York Businessman, Philanthropist Gives $30 Million To Research At The University of Texas MD Anderson Cancer Center
ImmunoCellular Therapeutics, Ltd Enters Into Sponsored Research Agreement With University of Texas MD Anderson Cancer Center To Advance Stem-To-T-Cell Program
ETView Medical, Ltd. And The University of Texas MD Anderson Cancer Center (Houston, TX) Announce The Start Of A Prospective, Randomized Clinical Evaluation Of Vivasight-DL Vs. Standard Double-Lumen Endotracheal Tubes
Tiny Particles In Blood Useful For Early Diagnosis Of Pancreatic Cancer, University of Texas MD Anderson Cancer Center Study
EXCLUSIVE: Nektar Therapeutics, University of Texas MD Anderson Cancer Center Team Up on Phase 1/2 Trial of NKTR-214
8 Signs Associated With Impending Death In Cancer Patients Identified, University of Texas MD Anderson Cancer Center Reveals